Network pharmacological analysis shows that Miaoyao Xuemaitong Capsule can alleviate intracerebral hemorrhage-induced inflammation and edema by regulating the TNFR1/NF-κB and TNFR1/MAPK signaling pathways (Zhang et al., 2021). The gene discussed is NFKB1; the disease is intracerebral hemorrhage.